DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS: CLINICAL FEATURES AND THERAPY

The article presents modern information about the causes, risk factors, course and methods of treatment of drug-induced toxic epidermal necrolysis. The above personal observation well illustrates the literature data regarding the etiology of the disease, the clinical picture and rational pharmacotherapy, including the features of local treatment.

Publication Details

Journal: Zenodo (CERN European Organization for Nuclear Research)
Published: 2025-01-26
DOI: https://doi.org/10.5281/zenodo.14741280
Primary Topic: Drug-Induced Adverse Reactions
Type: article
Field-Weighted Citation Impact: 0.00

Controls

|||

ALL TIME

JAN

FEB

MAR

APR

MAY

JUN

JUL

AUG

SEP

OCT

article

DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS: CLINICAL FEATURES AND THERAPY

Jan 26, 2025

Zenodo (CERN European Organization for Nuclear Research)

Drug-Induced Adverse Reactions

article

DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS: CLINICAL FEATURES AND THERAPY

January 26, 2025article en

Abstract

Zenodo (CERN European Organization for Nuclear Research)

Good health and well-being

Openalex Percentile: Top 56%

Drug-Induced Adverse Reactions

DOI Open Access PDF OpenAlex

AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

DRUG-INDUCED TOXIC EPIDERMAL NECROLYSIS: CLINICAL FEATURES AND THERAPY · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS